AI Science Tracker
EN

Digital kidney-biopsy damage features are associated with later graft loss

Icahn School of Medicine at Mount Sinai; University of Sydney · 30 Oct 2021 · medicine

Discovery

Digital kidney-biopsy damage features are associated with later graft loss

Source check: Source checked. Not independent scientific confirmation.

Finding: Deep-learning image analysis quantified tissue damage in 789 kidney-transplant biopsy slides from two cohorts. A damage score from 12-month biopsies was associated with subsequent graft loss in both cohorts. Baseline-score survival association was not confirmed in the smaller Australian cohort, and clinical utility remains untested.

Technology: Mask R-CNN and U-Net histopathology analysis

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Neural tissue/immune-cell segmentation supplied quantitative damage features, which ordinary survival analysis related to subsequent graft outcomes.
Test and result
Networks were developed on 60 selected biopsy slides and tested on 33 others. The pipeline then analyzed 478 baseline and 311 twelve-month slides from 404 GoCAR and 212 AUSCAD participants. In 200 GoCAR and 111 AUSCAD twelve-month biopsies, composite tissue/inflammation scores were associated with later death-censored graft loss; thresholds were derived in GoCAR.
Limitation / still unknown
This is retrospective image/outcome analysis of previously collected cohorts, not prospective evaluation of a frozen clinical tool. GoCAR supplies both selected model-development slides and outcome analyses, with exact patient overlap not separated here. Baseline ITAS survival association was not confirmed in AUSCAD. Observational associations, selected thresholds, limited graft-loss events and cohort differences prevent causal, treatment-benefit or universal surrogate-endpoint claims.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10285669/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 21 Nov 2026. Review scope: Primary full-text bibliographic dates, computational classification Methods, held-out Results and explicit cohort/reference limitations..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.